Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_1
2
40%
Ph phase_2
2
40%
Ph not_applicable
1
20%

Phase Distribution

2

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
75.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (40.0%)
Phase 22 (40.0%)
N/A1 (20.0%)

Trials by Status

terminated120%
completed360%
not_yet_recruiting120%

Recent Activity

0 active trials
Showing 5 of 5
not_yet_recruitingnot_applicable

Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia

NCT07495631
terminatedphase_1

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

NCT01350258
completedphase_2

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

NCT01350245
completedphase_2

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

NCT00405327
completedphase_1

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

NCT00429416

Clinical Trials (5)

Showing 5 of 5 trials
NCT07495631Not Applicable

Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia

Not Yet Recruiting
NCT01350258Phase 1

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Terminated
NCT01350245Phase 2

Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

Completed
NCT00405327Phase 2

A Pilot Study of Tumor Cell Vaccine for High-risk Solid Tumor Patients Following Stem Cell Transplantation

Completed
NCT00429416Phase 1

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5